investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Joseph H Antin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Scott A Armstrong

Targeting to Epigenetic Modications in ALL

Leukaemia

George A Calin

Protein-coding and non-coding RNA biomarkers for early detection of CLL

Leukaemia

Peter Aplan

Collaborative Pathways that Lead to Leukemia

Leukaemia

Pathology Hematology and hematologic malignancies

Elizabeth J Shpall

IMPROVING CORD BLOOD TRANSPLANTATION

Leukaemia

Pediatric oncology or childhood cancer

Charalampos Kalodimos

Mechanisms of autoinhibition and activation of the Abl kinase

Leukaemia

Margaret A Goodell

A Mouse Model of DNMT3A-Associated Hematologic Malignancy

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Danilo Perrotti

Role of microRNAs in the Regulation of CML Stem Cell Self Renewal and Survival

Leukaemia

Hematology and hematologic malignancies Pathology

Rachael Ann Clark

CTCL immunobiology: lessons from alemtuzumab

Non-Hodgkin lymphoma

George Thomas

The Function of rpL5 and rpL11 in Induction of p53

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology